Constellation Brands Q2 EPS Beats, Acquires SpikedAde for $75M Plus Earnout
STZ is trading near its 52-week low of $110.602 (1.7% above the low) on elevated volume (2.7× avg).
Summary
Constellation Brands reported strong Q2 FY2027 results with EPS up 25% and announced the acquisition of SpikedAde, a spirit-based RTD brand, for $75 million plus up to $278 million in earnouts. SpikedAde is a vodka-based, non-carbonated RTD with zero sugar and 100 calories, and Constellation will integrate it into its Beer Division and Gold Network distributors. The company raised its fiscal 2027 GAAP EPS guidance to $11.85-$12.55 from $11.50-$12.20.
Updated with a Benzinga report · What changed
Updates
· Benzinga — Constellation Brands raised fiscal 2027 GAAP EPS guidance to $11.85-$12.55 from $11.50-$12.20, versus the $11.93 estimate.
· Seeking Alpha — SpikedAde is a vodka-based, non-carbonated RTD with zero sugar and 100 calories; Constellation will integrate it into its Beer Division and Gold Network distributors.
- Constellation's goal is to enter the emerging “Ade” segment where alcoholic RTDs combine spirits with familiar sports drink flavors.
- SpikedAde's original formulation contained 4.5% alcohol by volume per 12-ounce serving.
· Reuters — SpikedAde acquisition does not impact fiscal 2027 outlook; FY2027 EPS view $11.71, revenue view $9.09 billion.
Key Events · Earnings and Guidance · STZ
-
New · · Seeking Alpha
Entry into Ade Segment
Constellation's goal is to enter the emerging “Ade” segment where alcoholic RTDs combine spirits with familiar sports drink flavors.
-
New · · Seeking Alpha
SpikedAde Original Formulation
SpikedAde's original formulation contained 4.5% alcohol by volume per 12-ounce serving.
-
Updated · · Seeking Alpha
SpikedAde Acquisition Completed
Acquired 100% of SpikedAde, a spirit-based RTD brand, for $75 million at close plus up to $278 million in contingent consideration over five years. SpikedAde is a vodka-based, non-carbonated RTD with zero sugar and 100 calories; Constellation will integrate it into its Beer Division and Gold Network distributors.
-
Updated · · Benzinga
FY2027 Guidance Updated
Reported EPS outlook raised to $11.85-$12.55 from $11.50-$12.20; comparable EPS outlook reaffirmed at $11.20-$11.90. Operating cash flow target of $2.4-$2.5 billion maintained.
-
Q2 EPS Beats Expectations
Reported EPS of $3.32, up 25% year-over-year; comparable EPS of $3.74, up 3%. Net sales grew 6% to $2.63 billion.
-
Dividend Declared
Quarterly cash dividend of $1.03 per Class A share declared, payable November 13, 2026 to shareholders of record October 30, 2026.
Analysis · STZ · Manufacturing
Constellation Brands delivered Q2 FY2027 reported EPS of $3.32, up 25% year-over-year, with comparable EPS of $3.74. The company also completed the acquisition of SpikedAde, a spirit-based RTD brand, for $75 million at close plus up to $278 million in contingent consideration. SpikedAde is a vodka-based, non-carbonated RTD with zero sugar and 100 calories; Constellation will integrate it into its Beer Division and Gold Network distributors, aiming to enter the emerging “Ade” segment where alcoholic RTDs combine spirits with familiar sports drink flavors. Management raised its fiscal 2027 GAAP EPS guidance to $11.85-$12.55 from $11.50-$12.20, versus the $11.93 estimate, while reaffirming comparable EPS guidance of $11.20-$11.90. The stock trades near its 52-week low, making the earnings beat and strategic expansion into the fast-growing RTD category particularly relevant for investors assessing the company's growth trajectory.
How filings like this one have moved
In the 30 days to Nov 10, 2026, 36.4% of the 3168 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, STZ was trading at $112.50 on NYSE in the Manufacturing sector, with a market capitalization of approximately $19.8B. The 52-week trading range was $110.60 to $168.60. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.